Business
Moolec Science Confirms Completion of First Phase of GLASO Industrialization Following Record 2025 Campaign; Advances 2026 Sowing and Expands Into Energy Applications
WARWICK, UK / ACCESS Newswire / April 29, 2026 / Moolec Science Limited, a wholly-owned subsidiary of Moolec Science SA (NASDAQ:MLEC) ("the Company";
About this update from Moolec Science Sa
[{"type":"text","content":"WARWICK, UK / ACCESS Newswire / April 29, 2026 / Moolec Science Limited, a wholly-owned subsidiary of Moolec Science SA (NASDAQ:MLEC) (\"the Company\"; \"Moolec\"), an innovation-driven company engineering plants and microbes to unlock scalable protein solutions for the global food industry, today announced the successful completion of the first phase of industrialization of its GLASO1 safflower platform, following a 2025 campaign that materially exceeded all internal forecasts.Building on previously reported results confirming approximately 45% GLA (\"Gamma-linolenic acid\") concentration at commercial scale, the Company has now validated not only agronomic and processing performance, but also the industrial-scale handling and availability of high-purity GLA output, marking a critical step toward full commercial deployment.Industrialization Milestone AchievedThe 2025 GLASO1 campaign delivered a tremendous volume of high-purity GLA output, surpassing expected yields and enabling Moolec to successfully complete the initial phase of industrialization, including large-scale harvesting, logistics coordination, and integration with downstream industrial processes.This scale has translated into available, ready-for-delivery end product, reinforcing the Company's transition from development to commercialization. While initial market traction has been centered in the pet food industry, the quality, traceability, and concentration profile of GLASO1-derived oils position the platform to expand into higher-value applications, including the human nutrition and dietary supplements markets, where demand for molecular farming-derived, high-performance functional lipids continues to grow.GLASO1 2026 Campaign UnderwayWith this foundation in place, Moolec is advancing the GLASO1 2026 campaign, with sowing scheduled to begin in early May, continuing its disciplined, execution-led scaling strategy across existing U.S. agricultural infrastructure.Advancing Next-Generation Safflower PlatformsIn parallel, Moolec continues to expand its safflower innovation pipeline through a strategic research collaboration with one of the largest global agribusiness and food companies, as previously disclosed by the Company.As part of this initiative, Moolec has accessed a germplasm library of 386 safflower varieties sourced from Australia and is currently in the fin...